madman
Super Moderator
US launch 2026!
UP YOUR NOSE AND UP IT GOES LOL!
* It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market
Tylah Tully chats with LTR Pharma (ASX:LTP) executive chairman Lee Rodne about its successful pre-Investigational New Drug Application meeting with the US FDA, a major milestone in the development of its erectile dysfunction product SPONTAN.It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market, valued over $6 billion dollars.
UP YOUR NOSE AND UP IT GOES LOL!
* It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market
Tylah Tully chats with LTR Pharma (ASX:LTP) executive chairman Lee Rodne about its successful pre-Investigational New Drug Application meeting with the US FDA, a major milestone in the development of its erectile dysfunction product SPONTAN.It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market, valued over $6 billion dollars.